Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-782-3
CAS number: 110-60-1
The primary route of excretion of EDA and its metabolites is via urine.
This is understandable because EDA and its known and probable
metabolites are all relatively small, watersoluble molecules.
In all three routes of excretion (urinary, fecal, respiratory), the
major portion was eliminated in the first 24 hours. However, at 500
mg/kg, higher rates of excretion during the 24-48 hour period are
evident; this is particularly true in the case of intravenous
administration . These observations are indicative of the involvement of
capacity-limited processes at the dosage level of 500 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again